Adaptive Biotechnologies Corporation
NASDAQ:ADPT
7.1 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 65.064 | 90.03 | 139.065 | 123.436 | 96.576 | 55.03 | 85.305 |
| Short Term Investments
| 281.337 | 408.166 | 213.996 | 564.833 | 480.29 | 109.988 | 106.845 |
| Cash and Short Term Investments
| 346.401 | 498.196 | 353.061 | 688.269 | 576.866 | 165.018 | 192.15 |
| Net Receivables
| 37.969 | 40.057 | 17.409 | 10.047 | 12.676 | 4.807 | 5.582 |
| Inventory
| 14.448 | 14.453 | 19.263 | 14.063 | 9.069 | 7.838 | 4.792 |
| Other Current Assets
| 11.37 | 9.44 | 13.015 | 14.535 | 25.458 | 3.055 | 2.723 |
| Total Current Assets
| 410.188 | 562.146 | 402.748 | 726.914 | 612.69 | 180.718 | 205.247 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 120.323 | 164.21 | 172.94 | 139.042 | 60.355 | 19.125 | 13.954 |
| Goodwill
| 118.972 | 118.972 | 118.972 | 118.972 | 118.972 | 118.972 | 118.972 |
| Intangible Assets
| 5.128 | 6.827 | 8.526 | 10.225 | 11.928 | 13.626 | 15.325 |
| Goodwill and Intangible Assets
| 124.1 | 125.799 | 127.498 | 129.197 | 130.9 | 132.598 | 134.297 |
| Long Term Investments
| 0 | 2.398 | 217.145 | 118.525 | 105.435 | 0.247 | 8.905 |
| Tax Assets
| 0 | -2.398 | 0 | 0 | 0 | -0.247 | 0 |
| Other Non-Current Assets
| 6.523 | 4.462 | 3.013 | 2.736 | 2.922 | 0.247 | 0.086 |
| Total Non-Current Assets
| 250.946 | 294.471 | 520.596 | 389.5 | 299.612 | 151.97 | 157.242 |
| Total Assets
| 661.134 | 856.617 | 923.344 | 1,116.414 | 912.302 | 332.688 | 362.489 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 7.719 | 8.084 | 3.307 | 3.237 | 4.453 | 1.793 | 1.964 |
| Short Term Debt
| 14.472 | 18.46 | 10.11 | 7.058 | 0 | 0 | 0 |
| Tax Payables
| 0.059 | 0.194 | 0.391 | 1.767 | 0 | 0 | 0 |
| Deferred Revenue
| 48.63 | 64.115 | 80.46 | 73.319 | 60.994 | 12.695 | 14.048 |
| Other Current Liabilities
| 22.223 | 18.935 | 19.539 | 19.816 | 12.866 | 8.312 | 4.991 |
| Total Current Liabilities
| 88.015 | 109.788 | 113.807 | 105.197 | 78.313 | 22.8 | 21.003 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 220.048 | 98.772 | 106.685 | 104.333 | 36.607 | 561.194 | 0 |
| Deferred Revenue Non-Current
| 44.793 | 58.599 | 98.75 | 163.618 | 219.332 | 0.704 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -98.75 | -163.618 | 6.918 | -561.194 | 0 |
| Other Non-Current Liabilities
| 0 | 125.36 | 0 | 0 | 7.011 | 6.102 | 566.102 |
| Total Non-Current Liabilities
| 264.841 | 282.731 | 205.435 | 267.951 | 262.95 | 568 | 566.102 |
| Total Liabilities
| 352.856 | 392.519 | 319.242 | 373.148 | 341.263 | 590.8 | 587.105 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 912.302 | 561.194 | 561.675 |
| Common Stock
| 0.014 | 0.014 | 0.014 | 0.014 | 0.012 | 0.001 | 0.001 |
| Retained Earnings
| -1,144.332 | -919.082 | -718.891 | -511.612 | -365.478 | -295.908 | -249.423 |
| Accumulated Other Comprehensive Income/Loss
| 0.215 | -4.116 | -1.137 | 0.893 | 0.671 | -0.107 | -0.166 |
| Other Total Stockholders Equity
| 1,452.502 | 1,387.349 | 1,324.006 | 1,253.971 | 935.834 | 37.902 | 24.972 |
| Total Shareholders Equity
| 308.399 | 464.165 | 603.992 | 743.266 | 571.039 | -258.112 | -224.616 |
| Total Equity
| 308.278 | 464.098 | 604.102 | 743.266 | 571.039 | -258.112 | -224.616 |
| Total Liabilities & Shareholders Equity
| 661.134 | 856.617 | 923.344 | 1,116.414 | 912.302 | 332.688 | 362.489 |